Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3921]
News [11368]
Articles [47]
Editorials [10]
Conferences [197]
elearning [4]
Neoadjuvant ipilimumab plus nivolumab in early stage colon cancer
Dr Myriam Chalabi - Netherlands Cancer Institute, Amsterdam, Netherlands
Neoadjuvant ipilimumab plus nivolumab in early stage colon cancer ( Dr Myriam Chalabi - Netherlands Cancer Institute, Amsterdam, Netherlands )
22 Oct 2018
Updates in head and neck cancers
Prof Jean-Pascal Machiels - University Clinic Saint-Luc, Brussels, Belgium
Updates in head and neck cancers ( Prof Jean-Pascal Machiels - University Clinic Saint-Luc, Brussels, Belgium )
22 Oct 2018
KEYNOTE022: Triplet therapy for BRAF melanoma
Prof Paolo Ascierto - Istituto Nazionale Tumori - IRCCS "Fondazione G.Pascale"...
KEYNOTE022: Triplet therapy for BRAF melanoma ( Prof Paolo Ascierto - Istituto Nazionale Tumori - IRCCS "Fondazione G.Pascale", Milan, Italy )
22 Oct 2018
First-line pembrolizumab for recurrent/metastatic head and neck squamous cell...
Prof Barbara Burtness - Yale University School of Medicine and Yale Cancer...
First-line pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma ( Prof Barbara Burtness - Yale University School of Medicine and Yale Cancer Center New Haven, USA )
22 Oct 2018
SPLENDOUR: Added denosumab in first line adv NSCLC treatment
Dr Solange Peters - Centre Hospitalier Universitaire Vaudois, Lausanne...
SPLENDOUR: Added denosumab in first line adv NSCLC treatment ( Dr Solange Peters - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland )
22 Oct 2018
Cisplatin superior to cetuximab for HPV oropharyngeal cancer
Prof Hisham Mehanna - University of Birmingham , Birmingham, UK
Cisplatin superior to cetuximab for HPV oropharyngeal cancer ( Prof Hisham Mehanna - University of Birmingham , Birmingham, UK )
22 Oct 2018
Cisplatin v cetuximab for HPV associated oropharyngeal cancer
Prof Hisham Mehanna - University of Birmingham , Birmingham, UK
Cisplatin v cetuximab for HPV associated oropharyngeal cancer ( Prof Hisham Mehanna - University of Birmingham , Birmingham, UK )
22 Oct 2018
ESMO 2018: Melanoma highlights
Dr Teresa Amaral, Will Davies
ESMO 2018: Melanoma highlights ( Dr Teresa Amaral, Will Davies )
22 Oct 2018
IMpower130: PFS and safety of adding atezolizumab to first-line NSCLC therapy
Dr Federico Cappuzzo - AUSL della Romagna-Ravenna, Ravenna, Italy
IMpower130: PFS and safety of adding atezolizumab to first-line NSCLC therapy ( Dr Federico Cappuzzo - AUSL della Romagna-Ravenna, Ravenna, Italy )
22 Oct 2018
KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck...
Prof Barbara Burtness - Yale Cancer Center, New Haven, USA
KEYNOTE048: First line pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma ( Prof Barbara Burtness - Yale Cancer Center, New Haven, USA )
22 Oct 2018
ESMO 2018: Highlights
Prof Gordon McVie , Will Davies
ESMO 2018: Highlights ( Prof Gordon McVie , Will Davies )
22 Oct 2018
IMpassion 130 trial results: Immunotherapy for metastatic breast cancer
Prof Peter Schmid - St Bartholomew Hospital London, UK
IMpassion 130 trial results: Immunotherapy for metastatic breast cancer ( Prof Peter Schmid - St Bartholomew Hospital London, UK )
22 Oct 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation